Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pelthos Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pelthos Therapeutics Inc. market cap is $100.88M.
What is the 52-week high for Pelthos Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pelthos Therapeutics Inc. 52 week high is $54.29 as of September 24, 2025.
What is the 52-week low for Pelthos Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pelthos Therapeutics Inc. 52 week low is $4.50 as of September 24, 2025.
What is Pelthos Therapeutics Inc. stock price today?
Pelthos Therapeutics Inc. stock price today is $33.96.
What was Pelthos Therapeutics Inc. stock price yesterday?
Pelthos Therapeutics Inc. stock price yesterday was $33.16.
What is the PE ratio of Pelthos Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pelthos Therapeutics Inc.’s P/E ratio is -1.92.
What is the Price-to-Book ratio of Pelthos Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pelthos Therapeutics Inc. P/B ratio is -5.3213.
What is the 50-day moving average of Pelthos Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pelthos Therapeutics Inc. 50-day moving average is $24.15.